Priority Date: 15.08.12 (US 201261683596P)

EXOSOME-BASED THERAPEUTICS AGAINST NEURODEGENERATIVE DISORDERS

  • Application ID: EP13829748
  • Status: GRANT OF PATENT INTENDED

Applicant

Research organisation logo small
Research Organisation

Attorney

operating since 2003
Headquarter in Mannheim and 3 offices
active in Legal Services and IP Consulting

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING) Isenbruck Bösl Hörschler LLP is specialized in the combination A61 and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Sperling Fischer & Heyner, Zacco Denmark A/S, Lederer Keller Patentanwälte Partnerschaft mbB and 172 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 15.08.2012 - Priority Date (US 201261683596P)
  • 20.02.2014 - Publication A1 (WO2014028763)
  • 24.06.2015 - Publication A1 (EP2885414)

IPC Classification